MedPath

Effects of Resistance Training Preconditioning on Skeletal Muscle Recovery From a Period of Disuse in Young Adults

Not Applicable
Not yet recruiting
Conditions
Atrophy, Muscular
Atrophy, Disuse
Interventions
Other: Resistance Training Preconditioning
Other: Control
Registration Number
NCT05760066
Lead Sponsor
Auburn University
Brief Summary

The goal of this clinical trial is to compare the effects of resistance training (RT) preconditioning vs no training on disuse-induced atrophy and post-disuse resistance training in young healthy individuals. The main questions it aims to answer are:

* To determine if performing RT prior to a period of disuse enhances the regain of strength, skeletal muscle size, and skeletal muscle quality while performing RT after a period of disuse.

* To determine if performing RT prior to a period of disuse dampens the maladaptive effects of disuse on muscle size, muscle quality, and strength.

* To determine the anabolic and proteolytic mechanisms underpinning the observed outcomes.

Participants will:

1. Perform either 6 weeks of resistance training or maintain an untrained lifestyle

2. Perform 2 weeks of limb immobilization induced disuse of a randomized leg

3. Perform 6 weeks of resistance training

Researchers will compare the resistance training preconditioning condition vs the non-trained condition to see if resistance training prior to a period of disuse is beneficial during the disuse period and in the return to training period on skeletal muscle size, strength, and underpinning molecular markers.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Between the ages of 18-30
  • Free from medical implants in lower extremity that would interfere with low-dose radiation
  • Are not allergic to ultrasound gel or Lidocaine
  • Have no or minimal experience with resistance training (less than 1 training session/week for a 1 year period)
Exclusion Criteria
  • Have been exposed to medically necessary radiation in the past 12 months other than dental x-rays
  • Have known overt cardiovascular or metabolic disease
  • Have a medical condition that would contraindicate participating in an exercise program or donating a skeletal muscle biopsy (e.g. blood clotting disorder, taking blood thinners, etc.)
  • Are undergoing medical treatment for a disease that would interfere physiologically or logistically with study outcomes and/or protocols (e.g. undergoing chemotherapy and/or radiation for cancer treatment)
  • Have consumed supplemental protein, creatine, and/or agents that affect hormone status (e.g. testosterone, growth hormone boosters, etc.) within the previous 2 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Resistance Training Preconditioning (PRECON)Resistance Training PreconditioningThis group will perform: 1. 6 weeks of lower body focused resistance training 2. 2 weeks of locking brace-induced immobilization of a randomized leg 3. 6 weeks of lower body focused resistance training
Control (CTL)ControlThis group will perform: 1. 6 weeks of activities of daily living (no training) 2. 2 weeks of locking brace-induced immobilization of a randomized leg 3. 6 weeks of lower body focused resistance training
Primary Outcome Measures
NameTimeMethod
Change in quadriceps strength via isokinetic dynamometryThrough completion of study, 16 weeks

Strength of the quadriceps will be assessed via isokinetic dynamometry

Change in vastus lateralis fiber cross-sectional areaThrough completion of study, 16 weeks

Upon the procurement and analysis of muscle from the vastus lateralis of participants, histological techniques will be used to assess fiber cross-sectional area of muscle fibers

Change in quadriceps strength via 3 repetition maximum testingThrough completion of study, 16 weeks

Strength of the quadriceps will be assessed via 3-repetition maximum testing of select exercises (leg press, leg extension, hex-bar deadlift)

Secondary Outcome Measures
NameTimeMethod
Change in activity of catabolic systemsThrough completion of study, 16 weeks

Activity assays will be performed and quantified in relative fluorescence units normalized to muscle soluble protein abundance in order to quantify the activity of the calpain system and the 20S proteasome core.

Gene expression at the mRNA level of atrophy-associated genes (atrogenes)Through completion of study, 16 weeks

Real time quantitative polymerase chain reactions (qPCR) will be used to quantify the expression of select genes associated with atrophy. These data will be reported as fold-change from baseline and will be normalized to one or more housekeeping genes whose value does not change throughout the duration of the study.

Change in protein expression of anabolic signaling proteinsThrough completion of study, 16 weeks

Western blotting will be performed and quantified in relative fluorescence units for proteins involved in the mechanistic target of rapamycin signaling pathway.

Change in protein expression of catabolic signaling proteinsThrough completion of study, 16 weeks

Western blotting will be performed and quantified in relative fluorescence units for proteins involved in the catabolic signaling pathways (e.g. ubiquitin-proteasome system, calpain system, autophagy).

© Copyright 2025. All Rights Reserved by MedPath